0001104659-19-019466.txt : 20190402 0001104659-19-019466.hdr.sgml : 20190402 20190402213920 ACCESSION NUMBER: 0001104659-19-019466 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190329 FILED AS OF DATE: 20190402 DATE AS OF CHANGE: 20190402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001446847 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38787 FILM NUMBER: 19727363 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc. CENTRAL INDEX KEY: 0001755237 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831895370 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 a4.xml 4 X0306 4 2019-03-29 1 0001755237 Cyclerion Therapeutics, Inc. CYCN 0001446847 IRONWOOD PHARMACEUTICALS INC IRONWOOD PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 0 0 1 0 Common Stock 2019-03-29 4 A 0 15562455 0.00 A 15562555 D Common Stock 2019-04-01 4 J 0 15562555 0.00 D 0 D On March 29, 2019, Cyclerion Therapeutics, Inc. ("Cyclerion") issued a dividend of 155,624.55 shares of its common stock for each share of its common stock outstanding. As the sole holder of Cyclerion's common stock, Ironwood Pharmaceuticals, Inc. ("Ironwood") received 15,562,455 shares of common stock in the dividend. Ironwood distributed all of the issued and outstanding shares of Cyclerion common stock to its stockholders on a pro rata basis as part of the separation of Cyclerion from Ironwood into two independent public companies. IRONWOOD PHARMACEUTICALS, INC. By: /s/ Conor Kilroy, Vice President, General Counsel and Secretary 2019-04-02